speb/financial-data huggingface dataset:
Financial ratios for 9229.T — annual report dated 2024-03-31
Total revenue: 132772054.93924987
Gross profit: 34000264.13100898
Operating income: 15009244.585314317
Net income: 5295826.730058108
Capital expenditures: 36245377.70734284
Operating cash flow: 16884574.749075543
Depreciation & amortization: 5388272.583201268
Net tangible assets: 34257791.86476492
Owner earnings: -25561278.394083463
Return on net tangible assets (%): -74.61449498843484
Capex to operating income (%): 241.4870215574131
Buffett classification: The Gruesome
Stock price: 18.205229793977814
P/E ratio: 111.49180119201996
Shares outstanding: 32432508
Book value: 34317221.34178552
P/B ratio: 17.205392448720417
Market cap (USD): 590441260.9350238
Debt to equity: 3.8685780257841067
Current ratio: 0.9708888601371458
Quick ratio: 0.969336266011127
Effective tax rate (%): 52.906635349383436
Interest coverage ratio: 3.5795275590551183
COGS to revenue (%): 74.38702939274879
Free cash flow (dilution-adjusted): -19380612.783940837
Buyback yield (%): 0
Retained earnings: 7217379.820390914
Inventory turnover: 1246.4166666666667
Receivables turnover: 5.043140205668423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.525605565334004
FCF margin (%): -14.596906549957728
Revenue growth (%): 28.93874101711928
Rule of 40 score: 14.341834467161553
Financial ratios for 9229.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 68419946.77125648
Buffett classification: The Gruesome
Stock price: 11.325115562403697
Shares outstanding: 32432508
Book value: 68482980.80963722
P/B ratio: 5.363404114951931
Market cap (USD): 367301901.0785824
Debt to equity: 2.2850276130087948
Current ratio: 2.008611955420466
Quick ratio: 2.0062478892266125
Buyback yield (%): 0
Retained earnings: 7662137.554279311
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9229.T — annual report dated 2025-03-31
Total revenue: 177088624.5154391
Gross profit: 32843202.780376952
Operating income: 7445528.672637348
Net income: -6182328.565699773
Capital expenditures: 28117898.676647507
Operating cash flow: 12585215.880229915
Depreciation & amortization: 9250100.25397674
Net tangible assets: 57498997.460232586
Owner earnings: -25050126.988370538
Return on net tangible assets (%): -43.5661978379635
Capex to operating income (%): 377.6481149012567
Buffett classification: The Gruesome
Stock price: 3.849752706857372
Shares outstanding: 32432508
Book value: 57585884.24007487
P/B ratio: 2.1681899498607238
Market cap (USD): 124857135.46317336
Debt to equity: 2.61014391829155
Current ratio: 1.779186004998215
Quick ratio: 1.7765083898607643
Interest coverage ratio: 1.3685503685503686
COGS to revenue (%): 81.45003019323673
Free cash flow (dilution-adjusted): -15579467.985563427
Buyback yield (%): 0
Retained earnings: -494586.2852559818
Inventory turnover: 1438.7333333333333
Receivables turnover: 6.513274336283185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3361284139913754
FCF margin (%): -8.797554347826088
Revenue growth (%): 33.377934533337125
Rule of 40 score: 24.58038018551104
Financial ratios for 9229.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 57498997.460232586
Buffett classification: The Gruesome
Stock price: 3.849752706857372
Shares outstanding: 32432508
Book value: 57585884.24007487
P/B ratio: 2.1681899498607238
Market cap (USD): 124857135.46317336
Debt to equity: 2.61014391829155
Current ratio: 1.779186004998215
Quick ratio: 1.7765083898607643
Buyback yield (%): 0
Retained earnings: -494586.2852559818
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9229.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.130916136174924
Shares outstanding: 32432508
Market cap (USD): 133975970.6338223
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9229.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 47725437.41588157
Buffett classification: The Gruesome
Stock price: 4.3741588156123825
Shares outstanding: 32432508
Book value: 47812920.59219378
P/B ratio: 2.9670837719915575
Market cap (USD): 141864940.7806191
Debt to equity: 4.089232934553134
Current ratio: 1.2752424415288077
Quick ratio: 1.2726754135767255
Buyback yield (%): 0
Retained earnings: -10706594.885598924
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9713.T — annual report dated 2022-03-31
Total revenue: 134936895.59088674
Gross profit: 102196361.25225373
Operating income: -67333224.06162925
Net income: -39427962.6290772
Capital expenditures: 7080806.4251762
Operating cash flow: -33601049.00835928
Depreciation & amortization: 11858711.686608752
Net tangible assets: 129372234.05999017
Owner earnings: -34650057.36764465
Return on net tangible assets (%): -26.783225642974788
Buffett classification: The Gruesome
Stock price: 9.326831666939846
Shares outstanding: 15273009
Book value: 131855433.53548604
P/B ratio: 1.0803406440760763
Market cap (USD): 142448783.99065727
Debt to equity: 1.9819131083348864
Current ratio: 0.6798300998737229
Quick ratio: 0.6343703363563311
Interest coverage ratio: -25.35802469135803
COGS to revenue (%): 24.2575159429092
SG&A to revenue (%): 70.31885818402672
Free cash flow (dilution-adjusted): -42263563.35027045
Buyback yield (%): 0.5753210085285393
Retained earnings: -38714964.75987543
Inventory turnover: 10.085858585858587
Receivables turnover: 13.407980456026058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.044054755999923
FCF margin (%): -31.32098390525357
Rule of 40 score: -31.32098390525357
Financial ratios for 9713.T — annual report dated 2023-03-31
Total revenue: 198175675.6756757
Gross profit: 155217717.71771774
Operating income: -22409909.90990991
Net income: 99962462.46246247
Capital expenditures: 413070570.5705706
Operating cash flow: 608108.1081081082
Depreciation & amortization: 10570570.570570571
Net tangible assets: 140217717.71771774
Owner earnings: -302537537.5375376
Return on net tangible assets (%): -215.7627027895272
Buffett classification: The Gruesome
Stock price: 10.02957957957958
P/E ratio: 1.5323938147547878
Shares outstanding: 15273009
Book value: 142214714.7147147
P/B ratio: 1.0771168053349525
Market cap (USD): 153181859.18513516
Debt to equity: 0.002006018054162488
Current ratio: 3.212363096343048
Quick ratio: 3.155374048635604
Effective tax rate (%): 0.09003601440576231
Interest coverage ratio: -8.627167630057803
COGS to revenue (%): 21.676705686252227
SG&A to revenue (%): 50.91866499981058
Free cash flow (dilution-adjusted): -3776276.2762762764
Buyback yield (%): 51.42173439321497
Retained earnings: 64496996.996997
Inventory turnover: 18.63843648208469
Receivables turnover: 12.9080684596577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.172243431394566
FCF margin (%): -1.9055195666174185
Revenue growth (%): 46.86544759153324
Rule of 40 score: 44.95992802491582
Financial ratios for 9713.T — annual report dated 2024-03-31
Total revenue: 136476492.34020075
Gross profit: 112645272.05493926
Operating income: 3691230.850501849
Net income: 5949550.977284733
Capital expenditures: 2832805.0713153724
Operating cash flow: -10723718.964606445
Depreciation & amortization: 1604595.8795562598
Net tangible assets: 129873217.11568938
Owner earnings: 4721341.785525621
Return on net tangible assets (%): 3.6353467561521255
Capex to operating income (%): 76.74418604651163
Buffett classification: The Gruesome
Stock price: 7.396988906497623
P/E ratio: 18.9887066390677
Shares outstanding: 15273009
Book value: 131240095.08716322
P/B ratio: 0.8608213676377359
Market cap (USD): 112974278.14183836
Debt to equity: 0.0019119496855345914
Current ratio: 3.867512332628612
Quick ratio: 3.788583509513742
Effective tax rate (%): -62.454873646209386
COGS to revenue (%): 17.46177665957035
SG&A to revenue (%): 46.14863557189858
Free cash flow (dilution-adjusted): -13827258.320126783
Buyback yield (%): 0
Retained earnings: 62678288.431061804
Inventory turnover: 10.741071428571429
Receivables turnover: 11.93991912189486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0467943319541577
FCF margin (%): -10.13160441261854
Revenue growth (%): -31.13358040794507
Rule of 40 score: -41.26518482056361
Financial ratios for 9713.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 133765233.225942
Buffett classification: The Gruesome
Stock price: 6.197576691413363
Shares outstanding: 15273009
Book value: 135032917.77559882
P/B ratio: 0.7009819986519709
Market cap (USD): 94655644.58614652
Debt to equity: 0
Current ratio: 3.626144688644689
Quick ratio: 3.5494505494505497
Buyback yield (%): 0
Retained earnings: 62235607.22790307
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9713.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 142247025.79869002
Buffett classification: The Gruesome
Stock price: 6.196698302365993
Shares outstanding: 15273009
Book value: 153956690.28204784
P/B ratio: 0.6147328106945952
Market cap (USD): 94642228.94232054
Debt to equity: 0.02747992185804211
Current ratio: 3.4640921409214087
Quick ratio: 3.3805329719963866
Buyback yield (%): 0
Retained earnings: 74167891.99304906
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9713.T — annual report dated 2025-03-31
Total revenue: 168186071.38083142
Gross profit: 140863520.91966313
Operating income: 6108808.982756316
Net income: 12271086.753107874
Capital expenditures: 3455420.3983424674
Operating cash flow: 8047052.533083812
Depreciation & amortization: 2546451.0092233657
Net tangible assets: 142247025.79869002
Owner earnings: 11362117.363988772
Return on net tangible assets (%): 7.987595733684161
Capex to operating income (%): 56.564551422319475
Buffett classification: The Good
Stock price: 6.196698302365993
P/E ratio: 7.71261998602941
Shares outstanding: 15273009
Book value: 153956690.28204784
P/B ratio: 0.6147328106945952
Market cap (USD): 94642228.94232054
Debt to equity: 0.02747992185804211
Current ratio: 3.4640921409214087
Quick ratio: 3.3805329719963866
Effective tax rate (%): 10.743801652892563
Interest coverage ratio: 304.6666666666667
COGS to revenue (%): 16.24542997933556
SG&A to revenue (%): 46.578445398187895
Free cash flow (dilution-adjusted): 4210667.023125251
Buyback yield (%): 0
Retained earnings: 74167891.99304906
Inventory turnover: 11.04864864864865
Receivables turnover: 12.293111871030774
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6935431585771963
FCF margin (%): 2.5035765379113024
Revenue growth (%): 23.23446221169493
Rule of 40 score: 25.738038749606233
Financial ratios for 9713.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.154096318848602
Shares outstanding: 15273009
Market cap (USD): 93991568.46464157
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9713.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 145148048.45222074
Buffett classification: The Gruesome
Stock price: 6.961440107671602
Shares outstanding: 15273009
Book value: 156823687.75235534
P/B ratio: 0.6779724347850153
Market cap (USD): 106322137.41742934
Debt to equity: 0.016864057672502573
Current ratio: 3.6777642770352363
Quick ratio: 3.586148238153098
Buyback yield (%): 0
Retained earnings: 76379542.39569314
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACB — annual report dated 2021-06-30
Total revenue: 234249193.5483871
Gross profit: -17385483.870967742
Operating income: -198907258.06451613
Net income: -559375000
Capital expenditures: 27291129.032258064
Operating cash flow: -169820161.29032257
Depreciation & amortization: 79093548.38709678
Net tangible assets: 631060483.8709677
Owner earnings: -507572580.6451613
Return on net tangible assets (%): -80.4316850156227
Buffett classification: The Gruesome
Stock price: 90.4
Shares outstanding: 61942146
Book value: 1643306451.6129034
P/B ratio: 3.4075019865613188
Market cap (USD): 5599569998.400001
Debt to equity: 0.19607891249938655
Current ratio: 5.721950590762621
Quick ratio: 4.538526315789474
Interest coverage ratio: -3.7124644399957853
COGS to revenue (%): 91.85489673596838
R&D to revenue (%): 3.9408680444384774
SG&A to revenue (%): 67.09080831345169
Free cash flow (dilution-adjusted): -228953225.80645162
Buyback yield (%): 0
Retained earnings: -3484745967.7419357
Inventory turnover: 1.9373225579250806
Receivables turnover: 5.142682624552955
Capitalized R&D asset: 9231451.612903226
ROCI (R&D-adjusted, %): -9.561300097114318
FCF margin (%): -97.73917354347623
Rule of 40 score: -97.73917354347623
Financial ratios for ACB — annual report dated 2022-06-30
Total revenue: 196358914.72868216
Gross profit: 16453488.372093024
Operating income: -170058139.5348837
Net income: -1331491472.868217
Capital expenditures: 9740310.07751938
Operating cash flow: -85478294.5736434
Depreciation & amortization: 72604651.1627907
Net tangible assets: 458253488.372093
Owner earnings: -1268627131.7829456
Return on net tangible assets (%): -276.8396016557641
Buffett classification: The Gruesome
Stock price: 13.2
Shares outstanding: 61942146
Book value: 513452713.1782946
P/B ratio: 1.5924277079748892
Market cap (USD): 817636327.1999999
Debt to equity: 0.40686853253698174
Current ratio: 5.694162329871539
Quick ratio: 4.624865310988331
Interest coverage ratio: -3.054809017865846
COGS to revenue (%): 79.00182785043998
R&D to revenue (%): 4.101412142769726
SG&A to revenue (%): 74.61182852157297
Free cash flow (dilution-adjusted): -121113953.48837209
Buyback yield (%): 0
Retained earnings: -4680833333.333333
Inventory turnover: 1.4301518670716453
Receivables turnover: 5.383469353056193
Capitalized R&D asset: 14238560.952738184
ROCI (R&D-adjusted, %): -22.268333144667896
Rosenberg metric: 3.6656176798633138
FCF margin (%): -61.67988535469379
Revenue growth (%): -16.175201393757728
Rule of 40 score: -77.85508674845151
Financial ratios for ACB — annual report dated 2024-03-31
Total revenue: 221614814.8148148
Gross profit: 97577037.03703703
Operating income: -23002222.22222222
Net income: -51352592.59259259
Capital expenditures: 3376296.296296296
Operating cash flow: -50746666.666666664
Depreciation & amortization: 24277777.777777776
Net tangible assets: 352402222.2222222
Owner earnings: -30451111.11111111
Return on net tangible assets (%): -8.641009957056646
Buffett classification: The Gruesome
Stock price: 4.39
Shares outstanding: 61942146
Book value: 445829629.6296296
P/B ratio: 0.6099325905411468
Market cap (USD): 271926020.94
Debt to equity: 0.17410902686626678
Current ratio: 3.4232466698764243
Quick ratio: 1.92769218424009
Interest coverage ratio: -2.2505435570372514
COGS to revenue (%): 46.09532722775587
R&D to revenue (%): 1.1939300755398088
SG&A to revenue (%): 52.12647904271675
Free cash flow (dilution-adjusted): -72636296.2962963
Buyback yield (%): 0
Retained earnings: -4716989629.629629
Inventory turnover: 0.7399450573035155
Receivables turnover: 6.588271564158464
Capitalized R&D asset: 11088142.167486317
ROCI (R&D-adjusted, %): -4.999834032936763
Rosenberg metric: 10.073094405407428
FCF margin (%): -32.77592085032422
Revenue growth (%): 12.862110243902011
Rule of 40 score: -19.91381060642221
Financial ratios for ACB — quarterly report dated 2024-09-30
Operating income: -1771851.8518518517
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.88
Shares outstanding: 61942146
Market cap (USD): 364219818.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACB — quarterly report dated 2024-12-31
Total revenue: 67117482.51748252
Gross profit: 52403496.503496505
Operating income: 22765034.965034965
Net income: 19965734.265734266
Capital expenditures: 3149650.34965035
Operating cash flow: 20167132.86713287
Depreciation & amortization: 3797202.797202797
Net tangible assets: 339865734.26573426
Owner earnings: 20613286.713286713
Return on net tangible assets (%): 6.0651264999753085
Capex to operating income (%): 13.835473367328133
Buffett classification: The Great
Stock price: 4.25
P/E ratio: 3.2963240544551855
Shares outstanding: 61942146
Book value: 428247552.44755244
P/B ratio: 0.6147241682887161
Market cap (USD): 263254120.5
Debt to equity: 0.16489547578846298
Current ratio: 3.298984693639149
Quick ratio: 1.6034230710180433
Effective tax rate (%): -1.3593913388382073
Interest coverage ratio: 16.474696356275302
COGS to revenue (%): 13.816707995582323
R&D to revenue (%): 0.9679301506595261
SG&A to revenue (%): 40.03104878201255
Free cash flow (dilution-adjusted): 15611188.811188811
Buyback yield (%): 0
Retained earnings: -4442705594.405595
Inventory turnover: 0.052207222635596656
Receivables turnover: 1.9383621124911645
Capitalized R&D asset: 649650.3496503497
ROCI (R&D-adjusted, %): 4.622539805074854
FCF margin (%): 23.259496968055178
Rule of 40 score: 23.259496968055178
Financial ratios for ACB — quarterly report dated 2025-03-31
Total revenue: 68036363.63636364
Gross profit: 15315384.615384616
Operating income: -19756643.356643356
Net income: -15339160.83916084
Capital expenditures: 2803496.5034965035
Operating cash flow: 2574825.1748251747
Depreciation & amortization: 4162937.062937063
Net tangible assets: 334361538.4615385
Owner earnings: -13979720.279720278
Return on net tangible assets (%): -4.181019247621497
Buffett classification: The Gruesome
Stock price: 4.39
Shares outstanding: 61942146
Book value: 425588111.8881119
P/B ratio: 0.6389417686824156
Market cap (USD): 271926020.94
Debt to equity: 0.17184447354627327
Current ratio: 4.3145864715910625
Quick ratio: 2.1579336658759005
Interest coverage ratio: -10.84113584036838
COGS to revenue (%): 70.54742424865353
R&D to revenue (%): 0.8068494840274637
SG&A to revenue (%): 49.848908440570646
Free cash flow (dilution-adjusted): -2100000
Buyback yield (%): 0
Retained earnings: -4452968531.468532
Inventory turnover: 0.28707239442392707
Receivables turnover: 2.290840593360019
Capitalized R&D asset: 984216.7832167833
ROCI (R&D-adjusted, %): -3.7725968583801133
Rosenberg metric: -57.089343379978466
FCF margin (%): -3.086584714056654
Revenue growth (%): 1.3690637437746185
Rule of 40 score: -1.7175209702820355
Financial ratios for ACB — annual report dated 2025-03-31
Total revenue: 223676923.07692307
Gross profit: 126539860.13986014
Operating income: 7296503.496503497
Net income: 1112587.4125874126
Capital expenditures: 9141958.041958041
Operating cash flow: 11193006.993006993
Depreciation & amortization: 8813986.013986014
Net tangible assets: 334361538.4615385
Owner earnings: 784615.384615384
Return on net tangible assets (%): 0.2346607771412794
Capex to operating income (%): 125.29231359018593
Buffett classification: The Gruesome
Stock price: 4.39
P/E ratio: 244.40868004035198
Shares outstanding: 61942146
Book value: 425588111.8881119
P/B ratio: 0.6389417686824156
Market cap (USD): 271926020.94
Debt to equity: 0.17184447354627327
Current ratio: 4.3145864715910625
Quick ratio: 2.1579336658759005
Effective tax rate (%): 13.56446716727912
Interest coverage ratio: 4.148707753479125
COGS to revenue (%): 33.75216502322906
R&D to revenue (%): 1.1492599841179525
SG&A to revenue (%): 50.15444353431835
Free cash flow (dilution-adjusted): -7393006.993006993
Buyback yield (%): 0
Retained earnings: -4452968531.468532
Inventory turnover: 0.4515355949358617
Receivables turnover: 7.531386861313869
Capitalized R&D asset: 7001050.903790439
ROCI (R&D-adjusted, %): 1.0354432495024202
Rosenberg metric: 10.946195741548488
FCF margin (%): -3.3052166899061457
Revenue growth (%): 0.9304920629207032
Rule of 40 score: -2.3747246269854427
Financial ratios for ACB — quarterly report dated 2025-06-30
Total revenue: 76244525.54744525
Gross profit: 20402189.781021897
Operating income: -14760583.941605838
Net income: -11101459.854014598
Capital expenditures: 3674452.5547445253
Operating cash flow: 7387591.240875912
Depreciation & amortization: 4512408.759124087
Net tangible assets: 336594890.5109489
Owner earnings: -10263503.649635036
Return on net tangible assets (%): -3.0492155225693125
Buffett classification: The Gruesome
Stock price: 4.24
Shares outstanding: 61942146
Book value: 429696350.36496353
P/B ratio: 0.6112099830890597
Market cap (USD): 262634699.04000002
Debt to equity: 0.17263761202954384
Current ratio: 2.9658730917551073
Quick ratio: 1.510902890652389
Interest coverage ratio: -11.39267605633803
COGS to revenue (%): 67.0834330572974
R&D to revenue (%): 0.7936431956344837
SG&A to revenue (%): 43.338279641951075
Free cash flow (dilution-adjusted): 2110218.9781021895
Buyback yield (%): 0
Retained earnings: -4659907299.270073
Inventory turnover: 0.3069792300986143
Receivables turnover: 2.669025960752249
Capitalized R&D asset: 1187291.307232913
ROCI (R&D-adjusted, %): -2.9618033330862987
Rosenberg metric: 9.26640941001441
FCF margin (%): 2.7676990091426927
Revenue growth (%): 12.06437480249836
Rule of 40 score: 14.832073811641052
Financial ratios for ACB — quarterly report dated 2025-09-30
Total revenue: 69274100.71942447
Gross profit: 23230935.251798563
Operating income: -13146043.165467627
Net income: -37031654.676258996
Capital expenditures: 4026618.7050359715
Operating cash flow: -29064028.77697842
Depreciation & amortization: 4485611.510791367
Net tangible assets: 339087769.7841727
Owner earnings: -36572661.8705036
Return on net tangible assets (%): -10.78560335389916
Buffett classification: The Gruesome
Stock price: 5.96
Shares outstanding: 61942146
Book value: 407985611.5107914
P/B ratio: 0.9048730635203667
Market cap (USD): 369175190.16
Debt to equity: 0.17692823135249514
Current ratio: 3.4149102452544393
Quick ratio: 1.6265509684488706
Interest coverage ratio: -8.223672367236723
COGS to revenue (%): 60.3119710045591
R&D to revenue (%): 0.9388208659168562
SG&A to revenue (%): 48.563209438057555
Free cash flow (dilution-adjusted): -37205755.39568345
Buyback yield (%): 0
Retained earnings: -4608599280.57554
Inventory turnover: 0.2616415274549026
Receivables turnover: 2.060405700346643
Capitalized R&D asset: 1236936.9160482958
ROCI (R&D-adjusted, %): -2.869348117489966
Rosenberg metric: 4.674766338919219
FCF margin (%): -53.70803086477448
Revenue growth (%): -9.142197132151137
Rule of 40 score: -62.85022799692562
Financial ratios for ACB — quarterly report dated 2025-12-31
Total revenue: 72389051.0948905
Gross profit: 34029197.08029197
Operating income: 1594160.5839416056
Net income: 1328467.1532846715
Capital expenditures: 3940145.9854014595
Operating cash flow: 12406569.343065692
Depreciation & amortization: 4665693.430656934
Net tangible assets: 346756934.30656934
Owner earnings: 2054014.5985401464
Return on net tangible assets (%): 0.5923499706351029
Capex to operating income (%): 247.16117216117217
Buffett classification: The Gruesome
Stock price: 4.22
P/E ratio: 49.19125314346154
Shares outstanding: 61942146
Book value: 414471532.8467153
P/B ratio: 0.630672640711063
Market cap (USD): 261395856.11999997
Debt to equity: 0.17786258466502064
Current ratio: 3.05503134957344
Quick ratio: 1.475149895501422
Interest coverage ratio: 1.037037037037037
COGS to revenue (%): 47.96769281961824
R&D to revenue (%): 1.313865669083319
SG&A to revenue (%): 40.403133917497705
Free cash flow (dilution-adjusted): 8444525.547445254
Buyback yield (%): 0
Retained earnings: -4674776642.335766
Inventory turnover: 0.20632807078417767
Receivables turnover: 2.2444439415199384
Capitalized R&D asset: 1586522.0290920548
ROCI (R&D-adjusted, %): 0.3925915839855262
Rosenberg metric: 16.60352205929849
FCF margin (%): 11.665473465560181
Revenue growth (%): 4.496558371912003
Rule of 40 score: 16.162031837472185
Financial ratios for ALVAZ.PA — annual report dated 2022-12-31
Total revenue: 15223403.191489363
Gross profit: 1042669.1489361703
Operating income: 96293.6170212766
Net income: 216781.91489361704
Capital expenditures: 0
Depreciation & amortization: 182511.70212765958
Net tangible assets: 2637607.446808511
Owner earnings: 399293.6170212766
Return on net tangible assets (%): 15.138477770997326
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.93617021276596
P/E ratio: 296.1006624953993
Shares outstanding: 2681685
Book value: 18179952.127659574
P/B ratio: 3.530772147598872
Market cap (USD): 64189268.61702128
Debt to equity: 0.08709441748290071
Current ratio: 7.132739583003764
Quick ratio: 6.946072072642136
Effective tax rate (%): -46.427960037524734
Interest coverage ratio: 6.202699924621394
COGS to revenue (%): 93.1508800245199
Buyback yield (%): 0
Retained earnings: 216781.91489361704
Inventory turnover: 112.96516949152543
Receivables turnover: 267.93736893349313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.48723067634826545
Rule of 40 score: 0
Financial ratios for ALVAZ.PA — annual report dated 2023-12-31
Total revenue: 30159095.555555556
Gross profit: 1576544.4444444445
Operating income: 364034.44444444444
Net income: 355805.55555555556
Capital expenditures: 0
Depreciation & amortization: 382437.77777777775
Net tangible assets: 3302712.222222222
Owner earnings: 738243.3333333333
Return on net tangible assets (%): 22.352638790811994
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.555555555555557
P/E ratio: 222.75843859786087
Shares outstanding: 2681685
Book value: 19265960
P/B ratio: 4.113923728690395
Market cap (USD): 79258690
Debt to equity: 0.08028627808955392
Current ratio: 5.721043031578761
Quick ratio: 5.590520287990691
Interest coverage ratio: 12.71316596173994
COGS to revenue (%): 94.77257386071038
Buyback yield (%): 0
Retained earnings: 355805.55555555556
Inventory turnover: 218.0025084745763
Receivables turnover: 27.099853334518105
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.749081765572615
Revenue growth (%): 98.11007549491946
Rule of 40 score: 98.11007549491946
Financial ratios for ALVAZ.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4555350
Buffett classification: The Gruesome
Stock price: 45.833333333333336
Shares outstanding: 2681685
Book value: 19341796.875
P/B ratio: 6.354661011814603
Market cap (USD): 122910562.5
Debt to equity: 0.0615632434615773
Current ratio: 1.9944168070017765
Quick ratio: 1.861994125467722
Buyback yield (%): 0
Retained earnings: 1279959.375
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVAZ.PA — annual report dated 2024-12-31
Total revenue: 42125101.04166667
Gross profit: 3756953.125
Operating income: 1212428.125
Net income: 1279959.375
Capital expenditures: 0
Depreciation & amortization: 421061.4583333334
Net tangible assets: 4555350
Owner earnings: 1701020.8333333335
Return on net tangible assets (%): 37.34116661361549
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 45.833333333333336
P/E ratio: 96.02692468266815
Shares outstanding: 2681685
Book value: 19341796.875
P/B ratio: 6.354661011814603
Market cap (USD): 122910562.5
Debt to equity: 0.0615632434615773
Current ratio: 1.9944168070017765
Quick ratio: 1.861994125467722
Effective tax rate (%): -7.02434623414897
Interest coverage ratio: 47.520965173723106
COGS to revenue (%): 91.08143830614452
Buyback yield (%): 0
Retained earnings: 1279959.375
Inventory turnover: 58.76442171162002
Receivables turnover: 23.970254787074825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.873022568780248
Revenue growth (%): 39.67627432350795
Rule of 40 score: 39.67627432350795
Financial ratios for ALVAZ.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.70588235294118
Shares outstanding: 2681685
Market cap (USD): 152067314.11764708
Quick ratio: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVU.PA — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.895348837209303
Shares outstanding: 9682407
Market cap (USD): 153905236.84883723
Buyback yield (%): 0.5809978041162306
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVU.PA — annual report dated 2022-09-30
Total revenue: 140597058.82352942
Gross profit: 74453921.56862745
Operating income: 4705882.352941177
Net income: 2688235.294117647
Capital expenditures: 256862.74509803922
Operating cash flow: -1373529.4117647058
Depreciation & amortization: 1744117.6470588236
Net tangible assets: 30495098.039215684
Owner earnings: 4175490.1960784313
Return on net tangible assets (%): 13.692332422440124
Capex to operating income (%): 5.458333333333333
Buffett classification: The Great
Stock price: 5.156862745098039
P/E ratio: 18.57383691466083
Shares outstanding: 9682407
Book value: 33509803.92156863
P/B ratio: 1.4900368876535983
Market cap (USD): 49930843.94117647
Debt to equity: 0.03759508484493856
Current ratio: 2.033675654098777
Quick ratio: 0.9131618100664078
Effective tax rate (%): 34.35480009576251
Interest coverage ratio: 64
COGS to revenue (%): 47.044467223117096
SG&A to revenue (%): 25.61694175400428
Free cash flow (dilution-adjusted): -3079411.7647058824
Buyback yield (%): 0.06479550238442913
Retained earnings: 0
Inventory turnover: 2.184921303193212
Receivables turnover: 61.44344473007712
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.50704899119228
FCF margin (%): -2.1902391063322386
Rule of 40 score: -2.1902391063322386
Financial ratios for ALVU.PA — annual report dated 2023-09-30
Total revenue: 170804210.5263158
Gross profit: 96062105.2631579
Operating income: 10961052.631578948
Net income: 7473684.210526316
Capital expenditures: 3085263.157894737
Operating cash flow: 22242105.263157897
Depreciation & amortization: 6963157.894736842
Net tangible assets: 35716842.10526316
Owner earnings: 11351578.94736842
Return on net tangible assets (%): 31.782146120067196
Capex to operating income (%): 28.147507922788822
Buffett classification: The Good
Stock price: 10.600000000000001
P/E ratio: 13.732653308450704
Shares outstanding: 9682407
Book value: 39674736.84210526
P/B ratio: 2.5868732188055508
Market cap (USD): 102633514.20000002
Debt to equity: 0.5716749356610332
Current ratio: 1.7979609126230607
Quick ratio: 0.9809529373959275
Effective tax rate (%): 26.133999167707035
Interest coverage ratio: 15.54179104477612
COGS to revenue (%): 43.75893605482424
SG&A to revenue (%): 24.588325198442046
Free cash flow (dilution-adjusted): 17126315.789473686
Buyback yield (%): 0.10563903367890226
Retained earnings: 7472631.578947369
Inventory turnover: 2.538885114599349
Receivables turnover: 65.00961538461539
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.7132716326714
FCF margin (%): 10.026869792437017
Revenue growth (%): 21.48491010804211
Rule of 40 score: 31.511779900479127
Financial ratios for ALVU.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 41188888.88888889
Buffett classification: The Gruesome
Stock price: 16.022222222222222
Shares outstanding: 9682407
Book value: 46053333.33333333
P/B ratio: 3.3685656470758545
Market cap (USD): 155133676.6
Debt to equity: 0.32819436402238955
Current ratio: 1.6714609398088858
Quick ratio: 0.8277263323810462
Buyback yield (%): 0
Retained earnings: 8226666.666666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVU.PA — annual report dated 2024-09-30
Total revenue: 198505555.55555555
Gross profit: 114968888.88888888
Operating income: 11986666.666666666
Net income: 8226666.666666666
Capital expenditures: 1524444.4444444445
Operating cash flow: 13894444.444444444
Depreciation & amortization: 7653333.333333333
Net tangible assets: 41188888.88888889
Owner earnings: 14355555.555555556
Return on net tangible assets (%): 34.85298084704613
Capex to operating income (%): 12.717834631071561
Buffett classification: The Great
Stock price: 16.022222222222222
P/E ratio: 18.857416118314426
Shares outstanding: 9682407
Book value: 46053333.33333333
P/B ratio: 3.3685656470758545
Market cap (USD): 155133676.6
Debt to equity: 0.32819436402238955
Current ratio: 1.6714609398088858
Quick ratio: 0.8277263323810462
Effective tax rate (%): 25.937781334400317
Interest coverage ratio: 16.64814814814815
COGS to revenue (%): 42.08278525649996
SG&A to revenue (%): 26.534941647309058
Free cash flow (dilution-adjusted): 10207777.777777778
Buyback yield (%): 0
Retained earnings: 8226666.666666666
Inventory turnover: 2.1945474181966786
Receivables turnover: 68.31931166347992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.852420991591767
FCF margin (%): 5.142313397330049
Revenue growth (%): 16.218186275315382
Rule of 40 score: 21.36049967264543
Financial ratios for ALVU.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 40208695.652173914
Buffett classification: The Gruesome
Stock price: 12.217391304347826
Shares outstanding: 9682407
Book value: 45814130.4347826
P/B ratio: 2.582036458278963
Market cap (USD): 118293755.08695652
Debt to equity: 0.2828062350233695
Current ratio: 1.5941726007708892
Quick ratio: 0.7651619084950241
Buyback yield (%): 0
Retained earnings: 5302173.913043478
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVU.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 48332941.17647059
Buffett classification: The Gruesome
Stock price: 17.235294117647058
Shares outstanding: 9682407
Book value: 55035294.11764705
P/B ratio: 3.032220234074391
Market cap (USD): 166879132.4117647
Debt to equity: 0.23670371953826427
Current ratio: 1.6667919273193483
Quick ratio: 0.8950684144211851
Buyback yield (%): 0
Retained earnings: 9580000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVU.PA — annual report dated 2025-09-30
Total revenue: 236352941.1764706
Gross profit: 138952941.17647058
Operating income: 13630588.235294119
Net income: 9580000
Capital expenditures: 3670588.2352941176
Operating cash flow: 22901176.470588237
Depreciation & amortization: 8618823.529411765
Net tangible assets: 48332941.17647059
Owner earnings: 14528235.294117644
Return on net tangible assets (%): 30.058661733563753
Capex to operating income (%): 26.929052304505436
Buffett classification: The Good
Stock price: 17.235294117647058
P/E ratio: 17.419533654672723
Shares outstanding: 9682407
Book value: 55035294.11764705
P/B ratio: 3.032220234074391
Market cap (USD): 166879132.4117647
Debt to equity: 0.23670371953826427
Current ratio: 1.6667919273193483
Quick ratio: 0.8950684144211851
Effective tax rate (%): 27.10589920329425
Interest coverage ratio: 21.258715596330276
COGS to revenue (%): 41.20955699352912
SG&A to revenue (%): 27.76754604280736
Free cash flow (dilution-adjusted): 15729411.764705883
Buyback yield (%): 0.005639869149522759
Retained earnings: 9580000
Inventory turnover: 2.3713909257561867
Receivables turnover: 59.12301353737493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.359438084176762
FCF margin (%): 6.655052264808363
Revenue growth (%): 19.066159390346506
Rule of 40 score: 25.721211655154868
Financial ratios for ASCN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.098901098901099
Shares outstanding: 34161259
Market cap (USD): 379152435.05494505
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCN.SW — annual report dated 2022-12-31
Total revenue: 323260869.5652174
Gross profit: 147934782.60869566
Operating income: 15108695.652173912
Net income: 11956521.739130434
Capital expenditures: 3369565.217391304
Operating cash flow: 11086956.52173913
Depreciation & amortization: 10760869.56521739
Net tangible assets: 47065217.391304344
Owner earnings: 19347826.08695652
Return on net tangible assets (%): 41.10854503464203
Capex to operating income (%): 22.302158273381295
Buffett classification: The Great
Stock price: 7.08695652173913
P/E ratio: 20.24830988
Shares outstanding: 34161259
Book value: 79782608.69565216
P/B ratio: 3.03448785667575
Market cap (USD): 242099357.26086956
Debt to equity: 0.13623978201634881
Current ratio: 1.7274749721913234
Quick ratio: 1.3092324805339264
Effective tax rate (%): 26.174496644295303
Interest coverage ratio: 23.166666666666664
COGS to revenue (%): 54.23671822461331
R&D to revenue (%): 8.977807666442501
SG&A to revenue (%): 31.80901143241426
Free cash flow (dilution-adjusted): -3478260.8695652173
Buyback yield (%): 0.26938275277647294
Retained earnings: 71521739.13043478
Inventory turnover: 4.289893617021276
Receivables turnover: 4.285302593659942
Capitalized R&D asset: 29021739.13043478
ROCI (R&D-adjusted, %): 22.87157287157288
FCF margin (%): -1.0759919300605245
Rule of 40 score: -1.0759919300605245
Financial ratios for ASCN.SW — annual report dated 2023-12-31
Total revenue: 353928571.42857146
Gross profit: 168333333.33333334
Operating income: 24047619.04761905
Net income: 20714285.714285716
Capital expenditures: 5357142.857142857
Operating cash flow: 38690476.190476194
Depreciation & amortization: 11785714.285714285
Net tangible assets: 55952380.952380955
Owner earnings: 27142857.14285714
Return on net tangible assets (%): 48.51063829787234
Capex to operating income (%): 22.277227722772277
Buffett classification: The Great
Stock price: 8.785714285714286
P/E ratio: 14.489085713793104
Shares outstanding: 34161259
Book value: 93690476.19047621
P/B ratio: 3.2034319113087673
Market cap (USD): 300131061.21428573
Debt to equity: 0
Current ratio: 1.6130820399113082
Quick ratio: 1.180709534368071
Effective tax rate (%): 13.861386138613863
Interest coverage ratio: 33.666666666666664
COGS to revenue (%): 52.43861419441641
R&D to revenue (%): 8.94719138916919
SG&A to revenue (%): 31.954254961318533
Free cash flow (dilution-adjusted): 19047619.04761905
Buyback yield (%): 0
Retained earnings: 91190476.1904762
Inventory turnover: 3.997435897435897
Receivables turnover: 5.385869565217392
Capitalized R&D asset: 51111231.88405797
ROCI (R&D-adjusted, %): 19.880319836619282
Rosenberg metric: 0.7028714107365795
FCF margin (%): 5.381769256643121
Revenue growth (%): 9.486982419060444
Rule of 40 score: 14.868751675703566
Financial ratios for ASCN.SW — annual report dated 2024-12-31
Total revenue: 318555555.5555555
Gross profit: 148111111.1111111
Operating income: 8444444.444444444
Net income: 4111111.111111111
Capital expenditures: 4777777.777777778
Operating cash flow: 22222222.22222222
Depreciation & amortization: 15222222.222222222
Net tangible assets: 47888888.88888889
Owner earnings: 14555555.555555554
Return on net tangible assets (%): 30.39443155452436
Capex to operating income (%): 56.57894736842106
Buffett classification: The Good
Stock price: 4.311111111111111
P/E ratio: 35.82315808648649
Shares outstanding: 34161259
Book value: 82666666.66666667
P/B ratio: 1.7815280231182793
Market cap (USD): 147272983.24444443
Debt to equity: 0
Current ratio: 1.586247086247086
Quick ratio: 1.1876456876456876
Effective tax rate (%): 42.1875
Interest coverage ratio: 9.5
COGS to revenue (%): 53.50540634809906
R&D to revenue (%): 9.97558423439135
SG&A to revenue (%): 33.79839553540286
Free cash flow (dilution-adjusted): 4111111.111111111
Buyback yield (%): 0
Retained earnings: 77222222.22222222
Inventory turnover: 4.485380116959065
Receivables turnover: 4.794314381270903
Capitalized R&D asset: 62571618.357487924
ROCI (R&D-adjusted, %): 5.273929239905958
Rosenberg metric: -0.6385964912280707
FCF margin (%): 1.290547610742937
Revenue growth (%): -9.994393990357683
Rule of 40 score: -8.703846379614745
Financial ratios for ASCN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 47888888.88888889
Buffett classification: The Gruesome
Stock price: 4.311111111111111
Shares outstanding: 34161259
Book value: 82666666.66666667
P/B ratio: 1.7815280231182793
Market cap (USD): 147272983.24444443
Debt to equity: 0
Current ratio: 1.586247086247086
Quick ratio: 1.1876456876456876
Buyback yield (%): 0
Retained earnings: 77222222.22222222
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASCN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 51375000
Buffett classification: The Gruesome
Stock price: 4.35
Shares outstanding: 34161259
Book value: 90250000
P/B ratio: 1.646553757894737
Market cap (USD): 148601476.64999998
Debt to equity: 0
Current ratio: 1.5597269624573378
Quick ratio: 1.1467576791808873
Buyback yield (%): 0
Retained earnings: 85125000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BFS — annual report dated 2021-12-31
Operating income: 61649000
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 40.16
Shares outstanding: 24535744
Market cap (USD): 985355479.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BFS — annual report dated 2022-12-31
Total revenue: 245860000
Gross profit: 181338000
Operating income: 109977000
Net income: 65392000
Capital expenditures: 0
Operating cash flow: 121151000
Depreciation & amortization: 48969000
Net tangible assets: 400484000
Owner earnings: 114361000
Return on net tangible assets (%): 28.555697605896864
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.38
P/E ratio: 12.149305583557622
Shares outstanding: 24535744
Book value: 521802000
P/B ratio: 1.5225456987899626
Market cap (USD): 794467390.72
Debt to equity: 2.343609261750626
Current ratio: 0.30611508892915573
Quick ratio: 0.30611508892915573
Interest coverage ratio: 2.616755496335776
COGS to revenue (%): 26.24339054746604
SG&A to revenue (%): 9.107622224029937
Free cash flow (dilution-adjusted): 119630000
Buyback yield (%): 0
Retained earnings: -273559000
Receivables turnover: 4.365179411608047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.848181427584017
FCF margin (%): 48.65777271617994
Rule of 40 score: 48.65777271617994
Financial ratios for BFS — annual report dated 2023-12-31
Total revenue: 257207000
Gross profit: 190068000
Operating income: 118179000
Net income: 69026000
Capital expenditures: 0
Operating cash flow: 117727000
Depreciation & amortization: 48430000
Net tangible assets: 348389000
Owner earnings: 117456000
Return on net tangible assets (%): 33.71403804368106
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 33.24
P/E ratio: 11.815375808535915
Shares outstanding: 24535744
Book value: 504429000
P/B ratio: 1.6168145181185063
Market cap (USD): 815568130.5600001
Debt to equity: 2.749645638930355
Current ratio: 0.1816851531265331
Quick ratio: 0.1816851531265331
Interest coverage ratio: 2.503898470274164
COGS to revenue (%): 26.10309983787377
SG&A to revenue (%): 9.120669344146933
Free cash flow (dilution-adjusted): 116306000
Buyback yield (%): 0
Retained earnings: -288825000
Receivables turnover: 4.590359080525414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.208396895812837
FCF margin (%): 45.21883152480298
Revenue growth (%): 4.61522817863825
Rule of 40 score: 49.83405970344123
Financial ratios for BFS — quarterly report dated 2024-09-30
Operating income: 19592000
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 37.2
Shares outstanding: 24535744
Market cap (USD): 912729676.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BFS — annual report dated 2024-12-31
Total revenue: 268847000
Gross profit: 196786000
Operating income: 121218000
Net income: 67703000
Capital expenditures: 0
Operating cash flow: 121224000
Depreciation & amortization: 50502000
Net tangible assets: 335754000
Owner earnings: 118205000
Return on net tangible assets (%): 35.205835224598964
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.9
P/E ratio: 12.647851138058876
Shares outstanding: 24535744
Book value: 501124000
P/B ratio: 1.7087536529880827
Market cap (USD): 856297465.6
Debt to equity: 3.0583568138823924
Current ratio: 0.23913790410744964
Quick ratio: 0.23913790410744964
Interest coverage ratio: 2.353656168692478
COGS to revenue (%): 26.803721075555988
SG&A to revenue (%): 9.32351858120046
Free cash flow (dilution-adjusted): 119501000
Buyback yield (%): 0
Retained earnings: -306541000
Receivables turnover: 5.2767865905120805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.481261669350751
FCF margin (%): 44.44944522349143
Revenue growth (%): 4.525537796405231
Rule of 40 score: 48.97498301989666
Financial ratios for BFS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.9
Shares outstanding: 24535744
Market cap (USD): 856297465.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BFS — quarterly report dated 2025-03-31
Total revenue: 71856000
Gross profit: 50130000
Operating income: 29595000
Net income: 12848000
Capital expenditures: 0
Operating cash flow: 30374000
Depreciation & amortization: 14523000
Net tangible assets: 328367000
Owner earnings: 27371000
Return on net tangible assets (%): 8.33549047255053
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.97
P/E ratio: 15.740649900373597
Shares outstanding: 24535744
Book value: 491736000
P/B ratio: 1.6450767885206696
Market cap (USD): 808943479.68
Debt to equity: 3.141114337774741
Current ratio: 0.21119949163751095
Quick ratio: 0.21119949163751095
Interest coverage ratio: 1.830694049239144
COGS to revenue (%): 30.23547094188377
SG&A to revenue (%): 8.366733466933868
Free cash flow (dilution-adjusted): 29946000
Buyback yield (%): 0
Retained earnings: -313879000
Receivables turnover: 1.4180052887082133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5904338587488371
FCF margin (%): 41.675016700066806
Rule of 40 score: 41.675016700066806
Financial ratios for BFS — quarterly report dated 2025-06-30
Total revenue: 70834000
Gross profit: 51394000
Operating income: 30881000
Net income: 14181000
Capital expenditures: 0
Operating cash flow: 26604000
Depreciation & amortization: 14098000
Net tangible assets: 322378000
Owner earnings: 28279000
Return on net tangible assets (%): 8.77200057075855
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.76
P/E ratio: 28.83033887454216
Shares outstanding: 24535744
Book value: 488274000
P/B ratio: 1.595938406386578
Market cap (USD): 779255229.44
Debt to equity: 3.2045101725670424
Current ratio: 0.21475604330416728
Quick ratio: 0.21475604330416728
Interest coverage ratio: 1.9028282703801835
COGS to revenue (%): 27.444447581669817
SG&A to revenue (%): 9.056385351667279
Free cash flow (dilution-adjusted): 26124000
Buyback yield (%): 0
Retained earnings: -320255000
Receivables turnover: 1.3461165694304555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6514221664160378
FCF margin (%): 36.880594064997034
Revenue growth (%): -1.4222890224894233
Rule of 40 score: 35.45830504250761
Financial ratios for BFS — quarterly report dated 2025-09-30
Total revenue: 72004000
Gross profit: 51826000
Operating income: 31062000
Net income: 13996000
Capital expenditures: 0
Operating cash flow: 20631000
Depreciation & amortization: 14106000
Net tangible assets: 316626000
Owner earnings: 28102000
Return on net tangible assets (%): 8.875455584822472
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.16
P/E ratio: 18.037734041194394
Shares outstanding: 24535744
Book value: 485205000
P/B ratio: 1.5251245124019743
Market cap (USD): 739998039.04
Debt to equity: 3.272965035397409
Current ratio: 0.2763623012354552
Quick ratio: 0.2763623012354552
Interest coverage ratio: 1.9112724587743046
COGS to revenue (%): 28.023443142047665
SG&A to revenue (%): 9.246708516193545
Free cash flow (dilution-adjusted): 20110000
Buyback yield (%): 0
Retained earnings: -326978000
Receivables turnover: 1.2211104704405928
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6249538335664762
FCF margin (%): 27.92900394422532
Revenue growth (%): 1.6517491600079057
Rule of 40 score: 29.580753104233228